483
Apnar Pharma Private LimitedApnar Pharma Private Limited – FDA 483, Sep 11, 2026
Record Details
An FDA inspection of Apnar Pharma Private Limited in Padra, India, revealed a significant deficiency in their systems for complying with the Drug Supply Chain Security Act (DSCSA). The firm lacked adequate procedures for verifying product, responding to illegitimate product notifications, identifying suspect products, and maintaining required records. This indicates a critical failure in ensuring the security and traceability of their drug supply chain.
View Company Profile
ID · 798177ba-2593-402f-b9bf-17de66f862da
Other documents for Apnar Pharma Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.